e-Drug3D 299 |
CHLORPROTHIXENE DISCONTINUED
|
cas 113-59-7 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL INJECTION |
ATC code |
PK parameters F 17 PERCENT (PMID10525070) |
Target TARGET D(2) DOPAMINE RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 |
Download SDF file | 3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine Formula: Calculated chemical properties: MW 315.85 NB_atoms 21 XLogP 5.19 PSA 5.838 NB_HD 0 NB_HA 1 fsp3 0.22 Lipinski(0=no;1=yes) 0 |
FDA NDA 012486 (pdf not found) INN (CHLORPROTHIXENE) TARACTAN (ROCHE) APPROVAL= AP YEAR= 1962 DISCONTINUED NDA 012487 (pdf not found) INN (CHLORPROTHIXENE) TARACTAN (ROCHE) APPROVAL= AP YEAR= 1962 DISCONTINUED NDA 016149 (pdf not found) INN (CHLORPROTHIXENE) TARACTAN (ROCHE) APPROVAL= AP YEAR= 1967 DISCONTINUED |
Other links: |